Drug intelligence / Profile preview

L04RD1

Development stage: Phase 1
Lead developer: Celltrion
Administration: Oral

Overview

L04RD1 is a drug developed by Celltrion, currently undergoing Phase 1 clinical trials. These trials are randomized, open-label, single-dose, two-sequence, two-period, crossover studies designed to evaluate the safety, tolerability, and pharmacokinetics of L04RD1 in healthy adult volunteers. The studies also aim to assess the bioequivalence of L04RD1 when administered as a single tablet, often in comparison to other investigational drugs such as L04TD1, L04TD2, and L04TD3.

Beyond the preview

Go deeper on L04RD1.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on L04RD1.

Explore the full profile